Ocular Therapeutix, Inc. (OCUL)

8.47 +0.31 (+3.80%) USD  |  NASDAQ  |  Jun 09, 16:00
8.49 +0.02 (+0.24%) After-Hours: 06:47
More

Ocular Therapeutix Total Operating Expenses (Quarterly)

Total Operating Expenses (Quarterly) Chart

View Total Operating Expenses (Quarterly) for OCUL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Operating Expenses (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Operating Expenses (Quarterly) Range, Past 5 Years

View Total Operating Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (Quarterly) Benchmarks

View Total Operating Expenses (Quarterly) Benchmarks
Start Trial
EyePoint, Inc. Upgrade
LENZ Therapeutics, Inc. Upgrade
Merck & Co., Inc. Upgrade
Zevra Therapeutics, Inc. Upgrade
Bristol Myers Squibb Co. Upgrade